What if we could slow the progression of Alzheimer’s disease with better sleep?
Recent research suggests there may be a link between sleep, cognitive dysfunction, and Alzheimer’s disease. ReCOGNITION is a research study testing whether an investigational medication, which has sleep promoting effects, can help to slow cognitive deterioration, or improve cognitive function.
We need people to participate in this research study who:
• Are between 60 to 85 years of age
• Have been diagnosed with mild dementia due to Alzheimer’s disease
• Do not have an alternative cause for dementia other than Alzheimer’s disease
• Have a caregiver who stays under the same roof at least 3 nights a week and is willing to attend all study visits
Qualified participants will be seen by a doctor and receive all study-related exams, care and medications at no cost. Compensation may be available.
If you’d like to enroll to this clinical trial, complete the form below and we’ll get back to you:
For more information, please call Estela Soniel at (973) 398 2900. You can also send an email to email@example.com.
ClinicalTrials.gov Identifier: NCT02615002 (NEUP-11-AD2)